Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 19/54
Jon
Kyl
U.S. Senate · R-AZ
Taken from pharma & insurers
$59,512
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 19/54
Pharma & Health$53,512
Insurers & HMOs$6,000
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 19 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$59,512
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Became a lobbyist for PhRMA, Pfizer, Eli Lilly and Merck a week after leaving the Senate.
Source: OpenSecrets; The Intercept
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$53,512
Johnson & Johnson$49,712
Amgen$2,000
Pfizer$1,000
Bristol Myers Squibb$800
Insurers & HMOs$6,000
Cigna$4,500
Anthem/Elevance$1,250
Aetna$250